Liliana Raquel Rodrigues Loureiro

Title: The Innovative Contributions of Liliana Raquel Rodrigues Loureiro

Introduction

Liliana Raquel Rodrigues Loureiro is a distinguished inventor based in Caparica, Portugal. With a focus on significant advancements in cancer research, she has made remarkable contributions to the field through her innovative invention of an antibody against tumor antigens. Her work aims to enhance the detection and treatment of human diseases, particularly cancer.

Latest Patents

Liliana holds a patent for the L2A5 antibody or functional fragment thereof, specifically targeting a unique group of antigens identified in cancer. This invention showcases her expertise in biotechnology, as it comprises nucleotide sequences derived from the L2A5 monoclonal antibody. The unique conjugation of DNA and amino acid sequences has opened new avenues for the detection, treatment, and prevention of human diseases, including cancer.

Career Highlights

Throughout her career, Liliana has been associated with prominent institutions that underscore her commitment to research and innovation. She has worked at both Universidade Nova de Lisboa and Instituto Português de Oncologia do Porto, where she engaged in cutting-edge research contributing to advancements in medical science.

Collaborations

Liliana has collaborated with several esteemed colleagues, including Paula Alexandra Quintela Videira and Carlos Manuel Mendes Novo. These partnerships have facilitated the sharing of knowledge and expertise, further enhancing the impact of her work in the scientific community.

Conclusion

Liliana Raquel Rodrigues Loureiro stands out as a significant figure in the realm of innovation and invention, particularly in cancer research. Her patented L2A5 antibody exemplifies her dedication to improving human health through science. As the landscape of medical technology evolves, her contributions remain vital in the ongoing fight against cancer.